Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q3 2025 · 10-Q
Revenue$224.50M$224.50M+10.5% vs Q3 2024 Net Income$9.93M$9.93M−46.3% vs Q3 2024 EPS Diluted$0.34$0.34−43.3% vs Q3 2024 Gross Profit$192,728,000+12.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flowderived$68,526,000+31.1% Free Cash Flowderived$58,087,000+31.2% Margins · derivedGross margin85.8%+1.8 pt vs Q3 2024
Operating margin4.3%−2.8 pt vs Q3 2024
Net margin4.4%−4.7 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 3, 2025 · 34 d after period end